CTSO - CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript
2024-03-14 22:24:03 ET
CytoSorbents Corporation (CTSO)
Q4 2023 Earnings Conference Call
March 14, 2024 04:30 PM ET
Company Participants
Eric Ribner - Moderator
Phillip P. Chan - Chief Executive Officer
Kathleen Bloch - Chief Financial Officer
Efthymios N. Deliargyris - Chief Medical Officer
Christian Steiner - Executive Vice President of Sales and Marketing
Conference Call Participants
Yuan Zhi - B. Riley
Thomas Kerr - Zacks Investment Research
Presentation
Operator
Good afternoon, and welcome to the CytoSorbents’ Fourth Quarter and Full-Year 2023 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company's request.
At this time, I'd like to turn the call over to our moderator, Eric Ribner. Please go ahead, Mr. Ribner.
Eric Ribner
Thank you, and good afternoon. Welcome to CytoSorbents’ fourth quarter and full-year 2023 financial and operating results conference call.
Joining me today from the company are Dr. Phil Chan, Chief Executive Officer; Vincent Capponi, President and Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Makis Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Executive Vice President of Sales and Marketing; and Managing Director of CytoSorbents Europe; Christopher Cramer, Senior Vice President of Business Development; and Dr. Irina Kulinets, Senior Vice President of Regulatory Affairs....
CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript